Siirry sisältöön

Seegene Multiplex PCR assays

Full panel high multiplex assays to maximize the test efficiency

Seegene’s superior accuracy based on DPO™, TOCE™ and MuDT™ technologies combined with All-in-One Platform is a unique streamlined automation solution that can perform a broad menu of molecular diagnostic tests in the area of infectious diseases. The platform allows molecular diagnostic method to be routinely used within clinically meaningful timeframe to reach therapeutic decision-making. The whole process is CE-IVD marked.

Multiplex-PCR with exceptional performance

  • DPO™ Technology is the innovative multiple targets amplification technology that enhances target specificity and minimizes the non-specific amplification commonly occurred in multiplex PCR.
  • TOCE™ technology enables to detect and differentiate multiple targets in a single tube and also can provide quantitative result by cyclic-CMTA analysis.
  • MUDT™ is the world’s first Real-time PCR technology that provides individual Ct values for multiple targets.
  • Seegene’s 3 Ct technology can provide the Ct value of three targets in one channel without compromising sensitivity and specificity. The successful development is based on Seegene’s 20-year expertise and combines 19 different patent technologies, including DPO™, TOCE™, and MuDT™.
  • Used algorithms enable semi quantitation of pathogens
  • Continuously evolving test panels meet clinical diagnostic needs.

Combine Allplex™ panels to find the best assay coverage for respiratory pathogens

  • Covers 20 virus/subtype and 7 bacteria species
  • Differenciates Influenza A subtypes
  • Targets e.g., Influenza A virus/A-H1/H1pdm09/A-H3, Influenza B virus, Respiratory syncytial virus A/B, Adenovirus, Enterovirus, Metapneumovirus, Parainfluenza virus 1/2/3/4, Bocavirus 1/2/3/4, Coronavirus 229E/NL63/OC43/ Human rhinovirus/ Bordetella parapertussis/ Bordetella pertussis/ Chlamydophila pneumoniae/ Haemophilus influenzae/ Legionella pneumophila/ Mycoplasma pneumoniae/ Streptococcus pneumoniae/ Sarbecovirus (E gene)/ SARS-CoV-2 N gene/(RdRP gene/multiple mutation sites of SARS-CoV-2
  • Differentiates SARS-CoV-2 virus, Influenza A, Influenza B, and RS virus
  • Specimens e.g., Nasopharyngeal swab, Nasopharyngeal aspirate, Bronchoalveolar lavage, Sputum

Manufacturer’s product page

Combine Allplex™ panels to find the best assay coverage for gastrointestinal tract pathogens

  • Covers 6 virus, 13 bacteria, 15 parasite/helminth species
  • Detects multiple hypervirulence markers
  • Targets e.g., EAEC, EPEC, Escherichia coli O157, ETEC, Hypervirulent Clostridium difficile, STEC, Aeromonas spp., Campylobacter spp., Clostridium difficile toxin B, Salmonella spp., Shigella spp., EIEC, Vibrio spp., Yersinia enterocolitica, Blastocystis hominis, Cryptosporidium spp., Cyclospora cayetanensis, Dientamoeba fragilis, Entamoeba histolytica, Giardia lamblia, Adenovirus, Astrovirus, Norovirus GI/ GII, Rotavirus, Sapovirus, Helicobacter pylori, Ancylostoma spp., Ascaris spp., Enterobius vermicularis, Enterocytozoon spp. / Encephalitozoon spp., Hymenolepis spp., Necator americanus, Strongyloides spp., Taenia spp., Trichuris trichiura

Specimens e.g., Stool, Fecal / Rectal swab, Gastric biopsy specimen

Manufacturer’s product page

Simultaneous detection of Mycobacterium tuberculosis and 25 mutations associated with MDR-TB with Allplex™, Anyplex™II and Anyplex™ panels.

  • Targets e.g., Isoniazid (7 mutations), Rifampicin (18 mutations), Fluoroquinolone (7 mutations)
  • Specimens e.g., Sputum, Bronchial washing, Cultured cell

Manufacturer’s product page

Combine Allplex™ panels to find the best assay coverage for sexually transmitted pathogens

  • Covers 17 bacteria, 4 virus and 7 Candida species
  • Targets e.g., Atopobium vaginae, Bacterial vaginosis–associated bacteria 2, Bacteroides fragilis, Gardnerella vaginalis, Lactobacillus spp., Megasphaera Type 1, Mobiluncus spp., Candida albicans, Candida dubliniensis, Candida glabrata, Candida krusei, Candida lusitaniae, Candida parapsilosis, Candida tropicalis, Cytomegalovirus, Haemophilus ducreyi, Herpes simplex virus type 1 / 2, Lymphogranuloma venereum, Treponema pallidum, Varicella-zoster virus, Chlamydia trachomatis, Mycoplasma genitalium, Mycoplasma hominis, Neisseria gonorrhoeae, Trichomonas vaginalis, Ureaplasma parvum, Ureaplasma urealyticum
  • Specimens e.g. Genital swab Liquid based cytology

Manufacturer’s product page

Allplex™ II HPV HR and HPV28 Detection to fulfill all clinical requirements for the primary cervical cancer screening.

  • Human Papillomavirus and detection of 28 different HPV types (19 high-risk and 9 low-risk)
  • Specimens e.g., Liquid based cytology, Cervical swab

Manufacturer’s product page

Simultaneous detection of gram + and gram – drug resistance genes using Allplex™ Entero-DR Assay

  • Covers 8 CPE, VRE and ESBL resistance genes
  • Targets e.g., CTX-M, IMP, KPC, NDM, OXA-48, vanA/B, VIM
  • Specimens e.g., Rectal swab, Bacterial colony

Manufacturer’s product page

Covers 12 viruses, 6 bacteria

  • Targets Escherichia coli K1, Group B Streptococcus, Haemophilus influenzae, Listeria monocytogenes, Neisseria meningitidis, Streptococcus pneumoniae, Adenovirus, Enterovirus, Human parechovirus, Mumps virus, Parvovirus B19, Cytomegalovirus, Epstein-Barr virus, Herpes simplex virus type 1 /2 / 6 / 7, Varicella-zoster virus
  • Specimens Cerebrospinal fluid (CSF)

Manufacturer’s product page

Product is available in the following countries:

  • Finland